New study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with type 2 diabetes compared to other diabetes medications.

Fire-breathing challenge reportedly leaves 14-year-old Pennsylvania girl intubated with burns after blowing isopropyl alcohol onto flame. Fire Chief Tommy Dick warns parents.

From calorie burn to gut health, does water temperature really make a difference? A dietitian explains the real impact of hot vs. cold hydration.

Conversation starters, celebrity health reveals, healthy living hacks and medical cautions: Here's what you missed in Fox News Health this week

A highly contagious respiratory virus, HMPV, is spreading on the West Coast and beyond. Experts warn of symptoms, severe risks and how to protect yourself.

New research suggests childhood cancer survivors may experience accelerated biological aging from treatments, potentially affecting memory and cognition.

Weight-loss drugs may prevent deadly heart complications by opening blocked blood vessels after heart attacks, groundbreaking new research reveals.

Comprehensive U.K. study of 8,000 participants finds collagen supplements improve skin elasticity and ease arthritis pain, but don't boost athletic performance.

Colorectal cancer rates are surging among younger adults, with those 65 and under now comprising 45% of new diagnoses compared to 27% in 1995.

Study finds middle-aged men are more vulnerable to faster biological aging from PFAS exposure. Research shows "forever chemicals" may accelerate aging.

Hope for Alzheimer's prevention emerges as scientists find existing seizure drug may stop disease progression if taken decades before symptoms appear.

New research reveals vegetarian seniors may be less likely than meat-eaters to reach 100 years old, challenging previous findings about plant-based diets.

Young Japanese monkey named Punch reaches major milestone, cuddling with a fellow macaque after being hand-reared with a stuffed orangutan toy at the Ichikawa Zoo.

University of Chicago researchers developed an mRNA nanoparticle system that triggers cells to produce PD-L1 protein, potentially delaying type 1 diabetes progression in animal models.